Revolution Medicines, Inc. <RVMD.O>: UBS Raises Target Price to $265 From $220
RVMD•Related News
France’s quantum computer maker Pasqal surges in Nasdaq debut
PSQL•
Flowers Foods declares quarterly dividend of $0.125 per share
FLO•
Soccer-Baleba out up to three weeks with ankle injury, Carrick says
MANU•
Nasdaq trade halt continues <UCFIW.O> reason not available at 09:33 AM
UCFIW•
Nasdaq Trade Halt <BRNX.O> Volatility Trading Pause at 09:33 AM
BRNX•